Intuitive Surgical, Inc.

Intuitive Surgical, Inc. faced a notable stock decline today, reaching an intraday low. Over the past week and month, the stock has shown significant decreases, with a year-to-date drop contrasting the S&P 500's gains. Despite this, the company maintains a strong financial position and robust long-term growth.

Intuitive Surgical, Inc. opened with a notable loss, contrasting with the broader market's modest decline. Over the past month, the company has experienced a significant performance drop. With a market cap of approximately USD 160.75 billion, it has a high P/E ratio and a positive return on equity, but no dividend yield.

Intuitive Surgical, Inc. has reached a new 52-week low, reflecting a notable decline in its stock performance over the past year. With a market capitalization of approximately USD 160.75 billion, the company exhibits a high P/E ratio and a solid return on equity, though it does not pay dividends.

Intuitive Surgical, Inc. faced a challenging trading session, with its stock price declining significantly. The company has struggled this year, underperforming the S&P 500, but remains financially strong, being net-debt free and showing consistent long-term growth in net sales and operational performance.

Intuitive Surgical, Inc. faced a decline on June 10, 2026, reaching an intraday low. Despite this, the company showed a slight weekly increase and maintains a strong financial position with no debt and a high return on equity. Its market capitalization stands at USD 160,753 million.

Intuitive Surgical, Inc. has reached a new 52-week low, reflecting a 1-year performance decline while the S&P 500 has gained significantly. The company, with a market cap of USD 171.69 billion, has a high P/E ratio of 60.00 and a return on equity of 16.17%, but does not offer dividends.

Intuitive Surgical, Inc. has reached a new 52-week low, reflecting a decline in stock performance with a one-year return of -1.46%. The company, with a market capitalization of USD 171,691 million, has a P/E ratio of 60.00 and a return on equity of 16.17%.

Intuitive Surgical, Inc. has reached a new 52-week low, reflecting significant volatility in its stock price over the past year. The company boasts a market capitalization of USD 171.69 billion and a P/E ratio of 60.00, indicating a premium valuation. Its return on equity stands at 16.17%, with a strong balance sheet.

Intuitive Surgical, Inc. has seen a notable increase in stock performance, reaching an intraday high of USD 491.15. The company has demonstrated strong management efficiency with a return on equity of 16.17% and a low debt-to-equity ratio, alongside an annual net sales growth rate of 18.22%.

Intuitive Surgical, Inc. saw a significant decline in its stock today, contrasting with the S&P 500's modest decrease. Over the past month, the company has underperformed the index, with a notable year-to-date decline. Despite these challenges, it maintains a strong market position and healthy growth metrics.

Intuitive Surgical, Inc. has a notably high P/E ratio of 60, reflecting its premium market valuation compared to peers. Despite a year-to-date decline, the company has achieved significant long-term returns. Its operational efficiency is highlighted by strong ROCE and ROE metrics, distinguishing it within the competitive Pharmaceuticals & Biotechnology sector.

Intuitive Surgical, Inc. faced a significant stock decline, contrasting with broader market trends. Over the past month, the company has seen a notable decrease, underperforming the market year-to-date. Despite these challenges, it maintains a strong market position and demonstrates healthy long-term growth metrics.

Intuitive Surgical, Inc. has recently adjusted its valuation, with its stock price at $452.66, down from $468.55. Over the past year, the company has seen a negative stock return, contrasting with the S&P 500's positive performance. Key financial metrics indicate solid operational performance amid varying industry valuations.

Intuitive Surgical, Inc. has recently encountered a technical event known as a Death Cross, indicating a potential shift in market sentiment. Current indicators reflect a bearish outlook, with the stock underperforming over the past year and year-to-date compared to the S&P 500.

Intuitive Surgical, Inc. has recently revised its market evaluation, with its stock priced at $496.70. Over the past year, the company has faced challenges, posting a return of -12.56%. Despite this, it has achieved a notable 111.48% return over the last three years, outperforming the S&P 500.

Intuitive Surgical, Inc. has recently experienced a change in its evaluation, reflecting its evolving market position. Key financial metrics indicate a premium valuation compared to peers, alongside strong operational efficiency and healthy growth, highlighted by significant increases in net sales and operating cash flow.